XML 39 R30.htm IDEA: XBRL DOCUMENT v3.22.1
Net Income Per Share (Tables)
3 Months Ended
Mar. 31, 2022
Earnings Per Share [Abstract]  
Schedule of Net Income Per Share Attributable to Common Stockholders For periods in which the Company reports net losses, basic and diluted net loss per share are the same because potentially dilutive common shares are not assumed to have been issued if their effect is anti-dilutive.
Three Months Ended March 31,
20212022
Numerator:
Net income$10,102 $32,692 
Denominator:
Weighted-average common shares outstanding used to calculate net income per share, basic73,629,122 84,230,445 
Weighted-average effect of dilutive securities17,820,449 11,227,331 
Weighted-average common shares outstanding used to calculate net income per share, diluted91,449,571 95,457,776 
Net income per share, basic$0.14 $0.39 
Net income per share, diluted$0.11 $0.34 
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The following securities were excluded from the computation of diluted net income per share for the periods presented, because including them would have been anti-dilutive. These amounts represent the number of instruments outstanding at the end of each respective period:

Three Months Ended March 31,
20212022
Options to purchase common stock617,424 718,911 
Unvested RSUs737,682 1,077,703 
Unvested PRSUs— 687,500 
Purchase rights committed under the ESPP— 2,620 
Convertible debt— 2,318,078 
Total1,355,106 4,804,812